Blood pressure

Closed Loop Medicine Demonstrates Application of Novel Drug Plus Software Product for Personalized Treatment of Hypertension

Retrieved on: 
Thursday, February 8, 2024

Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, today announced the publication of a peer-reviewed study in the Journal of the American Heart Association (JAHA) (1).

Key Points: 
  • Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, today announced the publication of a peer-reviewed study in the Journal of the American Heart Association (JAHA) (1).
  • Hypertension is the leading preventable cause of morbidity and premature death worldwide.
  • High adherence rates were reported (both app usage and medication) and patient retention was exceptionally high with no discontinuations due to drug intolerance.
  • Dr. Hakim Yadi OBE, CEO & Co-Founder of Closed Loop Medicine, commented: “These findings are invaluable in demonstrating the power of personalizing the dose of existing therapeutics in areas as widely impactful as hypertension.

Can kimchi really help you lose weight? Hold your pickle. The evidence isn’t looking great

Retrieved on: 
Thursday, February 8, 2024

For instance, there is some evidence eating or drinking fermented foods can improve blood glucose control in people with diabetes.

Key Points: 
  • For instance, there is some evidence eating or drinking fermented foods can improve blood glucose control in people with diabetes.
  • They can lower blood lipid (fats) levels and blood pressure in people with diabetes or obesity.
  • But can they help you lose weight, as a recent study suggests?

Remind me, what are fermented foods?

  • Fermented foods are ones prepared when microbes (bacteria and/or yeast) ferment (or digest) food components to form new foods.
  • As a result of fermentation, the food becomes acidic, extending its shelf life (food-spoilage microbes are less likely to grow under these conditions).
  • These postbiotics are thought to contribute to the health benefits of the fermented foods, alongside the health benefits of the bacteria themselves.

What does the evidence say?

  • The South Korean study involved 115,726 men and women aged 40-69 who reported how much kimchi they’d eaten over the previous year.
  • The study was funded by the World Institute of Kimchi, which specialises in researching the country’s national dish.
  • Eating one to three servings of any type of kimchi a day was associated with a lower risk of obesity in men.
  • And women who ate two to three serves a day of baechu were less likely to have obesity and abdominal obesity.

How about evidence from experimental trials?

  • There have been several experimental studies looking at how much weight people lose after eating various types of fermented foods.
  • Other studies looked at markers or measures of appetite, but not weight loss.
  • But this did not impact their appetite or whether they felt full.
  • A study in South Korea asked people to eat about 70g a day of chungkookjang (fermented soybean).
  • A systematic review of all studies that looked at the impact of fermented foods on satiety (feeling full) showed no effect.

What should I do?

  • These experimental studies have been short in length, and many did not report weight changes.
  • To date, most of the studies have used different fermented foods, so it is difficult to generalise across them all.
  • Nevertheless, fermented foods are still useful as part of a healthy, varied and balanced diet, particularly if you enjoy them.

Are there downsides?

  • The latest kimchi study said the average amount of kimchi South Koreans eat provides about 490mg of salt a day.
  • For an Australian, this would represent about 50% of the suggested dietary target for optimal health.


Evangeline Mantzioris is affiliated with Alliance for Research in Nutrition, Exercise and Activity (ARENA) at the University of South Australia. Evangeline Mantzioris has received funding from the National Health and Medical Research Council, and has been appointed to the National Health and Medical Research Council Dietary Guideline Expert Committee.

Medical Electronics Market to Reach $23.0 Billion, Globally, by 2032 at 6.73% CAGR: Allied Market Research

Retrieved on: 
Wednesday, February 7, 2024

WILMINGTON, Del., Feb. 7, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Medical Electronics Market Size, Share, Competitive Landscape and Trend Analysis Report by Component (Sensors, Batteries, Displays, MPUs/MCUs, Others), by Application (Medical imaging, Clinical, diagnostic, and therapeutics, Patient monitoring, Flow measurement, Cardiology, Others), by End Use (Hospitals, Ambulatory surgical centers, Home care, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, The global medical electronics market was valued at $11.8 billion in 2022, and is projected to reach $23.0 billion by 2032, growing at a CAGR of 6.7% from 2023 to 2032.

Key Points: 
  • The significance of sensors lies in their pivotal role within the medical electronics domain, encompassing tangible components crucial for monitoring and communication in medical devices.
  • On the basis of application, the medical imaging segment held the highest market share in 2022, accounting for nearly two-fifth of the global medical electronics market revenue and is estimated to maintain its leadership status during the forecast period.
  • On the basis of region, North America held the highest market share in terms of revenue in 2022, accounting for more than one-third of the global medical electronics market revenue.
  • North America dominates the medical electronics market due to its advanced healthcare infrastructure, early adoption of innovative medical technologies, and a proactive approach to integrating digital health solutions, fostering sustained market leadership.

Medical Electronics Market to Reach $23.0 Billion, Globally, by 2032 at 6.73% CAGR: Allied Market Research

Retrieved on: 
Wednesday, February 7, 2024

WILMINGTON, Del., Feb. 7, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Medical Electronics Market Size, Share, Competitive Landscape and Trend Analysis Report by Component (Sensors, Batteries, Displays, MPUs/MCUs, Others), by Application (Medical imaging, Clinical, diagnostic, and therapeutics, Patient monitoring, Flow measurement, Cardiology, Others), by End Use (Hospitals, Ambulatory surgical centers, Home care, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, The global medical electronics market was valued at $11.8 billion in 2022, and is projected to reach $23.0 billion by 2032, growing at a CAGR of 6.7% from 2023 to 2032.

Key Points: 
  • The significance of sensors lies in their pivotal role within the medical electronics domain, encompassing tangible components crucial for monitoring and communication in medical devices.
  • On the basis of application, the medical imaging segment held the highest market share in 2022, accounting for nearly two-fifth of the global medical electronics market revenue and is estimated to maintain its leadership status during the forecast period.
  • On the basis of region, North America held the highest market share in terms of revenue in 2022, accounting for more than one-third of the global medical electronics market revenue.
  • North America dominates the medical electronics market due to its advanced healthcare infrastructure, early adoption of innovative medical technologies, and a proactive approach to integrating digital health solutions, fostering sustained market leadership.

Digital Biomarkers Market to Worth $8.58 Billion by 2029, Increasing Adoption of Digital Health Solutions Propels the Market Expansion - Arizton

Retrieved on: 
Tuesday, February 6, 2024

The global digital biomarkers market is poised for continued growth and innovation as it continues to redefine healthcare and pharmaceutical research.

Key Points: 
  • The global digital biomarkers market is poised for continued growth and innovation as it continues to redefine healthcare and pharmaceutical research.
  • While initially developed for monitoring and diagnosing physical health conditions, digital biomarkers have expanded their horizons to encompass mental health.
  • This expansion into mental health has fueled the growth of the global digital biomarkers market.
  • Moreover, in 2023, the mobile application & software segment accounted for 21.22% of the market share of the global digital biomarkers market.

Digital Biomarkers Market to Worth $8.58 Billion by 2029, Increasing Adoption of Digital Health Solutions Propels the Market Expansion - Arizton

Retrieved on: 
Tuesday, February 6, 2024

The global digital biomarkers market is poised for continued growth and innovation as it continues to redefine healthcare and pharmaceutical research.

Key Points: 
  • The global digital biomarkers market is poised for continued growth and innovation as it continues to redefine healthcare and pharmaceutical research.
  • While initially developed for monitoring and diagnosing physical health conditions, digital biomarkers have expanded their horizons to encompass mental health.
  • This expansion into mental health has fueled the growth of the global digital biomarkers market.
  • Moreover, in 2023, the mobile application & software segment accounted for 21.22% of the market share of the global digital biomarkers market.

Preamble Debuts as New Membership Longevity Service Harnessing the Three Emerging Trends in Healthcare: Biohacking, Healthspan and Personalized Care

Retrieved on: 
Tuesday, February 6, 2024

Today, Preamble debuts as a healthspan and longevity membership program tackling the phenomenon of medicine 3.0 and the imperative need for a revolution within the healthcare industry.

Key Points: 
  • Today, Preamble debuts as a healthspan and longevity membership program tackling the phenomenon of medicine 3.0 and the imperative need for a revolution within the healthcare industry.
  • The healthspan membership program promises a future where treatments are personalized and technology plays a pivotal role in enhancing patient care.
  • “I founded Preamble with the aim of prioritizing proactive patient care, emphasizing prevention and performance enhancement over merely providing temporary solutions.
  • To join Preamble, membership starts at $2,500 annually with limited availability for founding member spots.

The emotion recognition and sentiment analysis software market to grow by USD 797.17 million from 2023 to 2028; North America accounts for 44% of market growth - Technavio

Retrieved on: 
Tuesday, February 6, 2024

NEW YORK, Feb. 5, 2024 /PRNewswire/ -- The emotion recognition and sentiment analysis software market size is estimated to grow by USD 797.17 million from 2023 to 2028, according to Technavio.

Key Points: 
  • NEW YORK, Feb. 5, 2024 /PRNewswire/ -- The emotion recognition and sentiment analysis software market size is estimated to grow by USD 797.17 million from 2023 to 2028, according to Technavio.
  • By geography, the global emotion recognition and sentiment analysis software market is segmented into North America, Europe, APAC, South America, and Middle East, and Africa.
  • What are the key data covered in this Emotion Recognition and Sentiment Analysis Software Market report?
  • Growth of the Emotion Recognition and Sentiment Analysis Software Market industry across North America, Europe, APAC, South America, and Middle East and Africa
    Gain instant access to 17,000+ market research reports.

Toku Obtains CE and UKCA Marks for AI Cardiovascular Risk Assessments Through the Eye

Retrieved on: 
Monday, February 5, 2024

Toku, Inc., a commercial medical device company specializing in AI assessment of retinal images, announced today that it has obtained CE and UKCA Marks for its patented CLAiR technology.

Key Points: 
  • Toku, Inc., a commercial medical device company specializing in AI assessment of retinal images, announced today that it has obtained CE and UKCA Marks for its patented CLAiR technology.
  • The CLAiR technology integrates readily with existing retinal cameras, to provide real-time CVD risk assessments with accuracy comparable to gold standard cardiovascular risk assessments (which typically require blood tests and can take weeks).
  • The AI-powered CLAiR technology identifies elevated cardiovascular risk by analyzing minute changes in the retina and its vasculature.
  • CLAiR will enable healthcare providers in various settings to identify elevated cardiovascular risk in adult patients with no known history of cardiovascular disease.

Sapiens and Binah.ai Partner to Empower Global Life Insurers to Improve Risk Management with AI

Retrieved on: 
Monday, February 5, 2024

HOLON, Israel, Feb. 5, 2024 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, and Binah.ai, the number one health and wellness check software provider, today announced a partnership to empower more insurance companies worldwide to use client-provided health data for improved risk management and value-added services at reduced costs. The partnership enables Binah.ai to leverage Sapiens' strong global presence and provide Sapiens' customers with seamless access to Binah.ai's software-based health and wellness check technology.

Key Points: 
  • The partnership enables Binah.ai to leverage Sapiens' strong global presence and provide Sapiens' customers with seamless access to Binah.ai's software-based health and wellness check technology.
  • "We are extremely excited to partner with Sapiens, a leading player in the global insurtech sector.
  • Sapiens' cloud-based SaaS insurance platform offers pre-integrated, low-code capabilities across core, data, and digital domains to accelerate our customers' digital transformation.
  • To learn more about how this partnership is empowering insurers with innovative solutions, please click here .